AIGH Capital Management LLC raised its holdings in Biofrontera Inc. (NASDAQ:BFRI – Free Report) by 61.8% in the fourth quarter, Holdings Channel.com reports. The fund owned 811,097 shares of the company’s stock after acquiring an additional 309,663 shares during the quarter. Biofrontera makes up about 0.3% of AIGH Capital Management LLC’s investment portfolio, making the stock its 29th largest position. AIGH Capital Management LLC owned about 0.10% of Biofrontera worth $884,000 at the end of the most recent reporting period.
Separately, Rosalind Advisors Inc. lifted its stake in shares of Biofrontera by 63.9% in the 4th quarter. Rosalind Advisors Inc. now owns 811,918 shares of the company’s stock valued at $885,000 after purchasing an additional 316,428 shares during the last quarter. Hedge funds and other institutional investors own 10.08% of the company’s stock.
Biofrontera Trading Down 4.1 %
Shares of NASDAQ:BFRI opened at $0.81 on Friday. The stock has a market capitalization of $7.21 million, a PE ratio of -0.36 and a beta of 0.30. Biofrontera Inc. has a 1 year low of $0.65 and a 1 year high of $2.43. The firm has a fifty day moving average price of $1.02 and a 200 day moving average price of $1.02.
Biofrontera Profile
Biofrontera Inc, a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection.
Recommended Stories
- Five stocks we like better than Biofrontera
- P/E Ratio Calculation: How to Assess Stocks
- MarketBeat Week in Review – 03/24 – 03/28
- What is the MACD Indicator and How to Use it in Your Trading
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- What is an Earnings Surprise?
- 4 Healthcare Stocks With Massive Gains—and More to Come
Want to see what other hedge funds are holding BFRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Biofrontera Inc. (NASDAQ:BFRI – Free Report).
Receive News & Ratings for Biofrontera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biofrontera and related companies with MarketBeat.com's FREE daily email newsletter.